Human AAT is an acute phase protein with a broad-protease inhibitory and immunomodulatory activities used as a therapeutic for emphysema patients with inherited AAT deficiency. This evidence concerns the gene SERPINA1 and hyperinsulinemic hypoglycemia, familial, 4.